Diana A - Search Results

1

Epigenetic Regulation in Melanoma: Facts and Hopes.

Giunta EF, Arrichiello G, Curvietto M, Pappalardo A, Bosso D, Rosanova M, Diana A, Giordano P, Petrillo A, Federico P, Fabozzi T, Parola S, Riccio V, Mucci B, Vanella V, Festino L, Daniele B, Ascierto PA, Ottaviano M, On Behalf Of Scito Youth. Giunta EF, et al. Among authors: diana a. Cells. 2021 Aug 11;10(8):2048. doi: 10.3390/cells10082048. Cells. 2021. PMID: 34440824 Free PMC article. Review.

2

Triple-Negative Breast Cancers: Systematic Review of the Literature on Molecular and Clinical Features with a Focus on Treatment with Innovative Drugs.

Diana A, Franzese E, Centonze S, Carlino F, Della Corte CM, Ventriglia J, Petrillo A, De Vita F, Alfano R, Ciardiello F, Orditura M. Diana A, et al. Curr Oncol Rep. 2018 Aug 20;20(10):76. doi: 10.1007/s11912-018-0726-6. Curr Oncol Rep. 2018. PMID: 30128845

3

Cancer Treatment-Induced Bone Loss (CTIBL): State of the Art and Proper Management in Breast Cancer Patients on Endocrine Therapy.

Diana A, Carlino F, Giunta EF, Franzese E, Guerrera LP, Di Lauro V, Ciardiello F, Daniele B, Orditura M. Diana A, et al. Curr Treat Options Oncol. 2021 Apr 16;22(5):45. doi: 10.1007/s11864-021-00835-2. Curr Treat Options Oncol. 2021. PMID: 33864145 Free PMC article. Review.

4

Bone Metastases from Gastric Cancer: What We Know and How to Deal with Them.

Petrillo A, Giunta EF, Pappalardo A, Bosso D, Attademo L, Cardalesi C, Diana A, Fabbrocini A, Fabozzi T, Giordano P, Ottaviano M, Rosanova M, Silvestri A, Federico P, Daniele B. Petrillo A, et al. Among authors: diana a. J Clin Med. 2021 Apr 19;10(8):1777. doi: 10.3390/jcm10081777. J Clin Med. 2021. PMID: 33921760 Free PMC article. Review.

5

Prognostic Relevance of Progesterone Receptor Levels in Early Luminal-Like HER2 Negative Breast Cancer Subtypes: A Retrospective Analysis.

Diana A, Carlino F, Buono G, Antoniol G, Famiglietti V, De Angelis C, Carrano S, Piccolo A, De Vita F, Ciardiello F, Daniele B, Arpino G, Orditura M. Diana A, et al. Front Oncol. 2022 Mar 28;12:813462. doi: 10.3389/fonc.2022.813462. eCollection 2022. Front Oncol. 2022. PMID: 35419293 Free PMC article.

6

Immune-Based Therapy in Triple-Negative Breast Cancer: From Molecular Biology to Clinical Practice.

Carlino F, Diana A, Piccolo A, Ventriglia A, Bruno V, De Santo I, Letizia O, De Vita F, Daniele B, Ciardiello F, Orditura M. Carlino F, et al. Among authors: diana a. Cancers (Basel). 2022 Apr 23;14(9):2102. doi: 10.3390/cancers14092102. Cancers (Basel). 2022. PMID: 35565233 Free PMC article. Review.

7

Pancreatic neuroendocrine tumors: Nosography, management and treatment.

Orditura M, Petrillo A, Ventriglia J, Diana A, Laterza MM, Fabozzi A, Savastano B, Franzese E, Conzo G, Santini L, Ciardiello F, De Vita F. Orditura M, et al. Among authors: diana a. Int J Surg. 2016 Apr;28 Suppl 1:S156-62. doi: 10.1016/j.ijsu.2015.12.052. Epub 2015 Dec 18. Int J Surg. 2016. PMID: 26708853 Free article. Review.

8

NAB-paclitaxel and gemcitabine in metastatic pancreatic ductal adenocarcinoma (PDAC): from clinical trials to clinical practice.

De Vita F, Ventriglia J, Febbraro A, Laterza MM, Fabozzi A, Savastano B, Petrillo A, Diana A, Giordano G, Troiani T, Conzo G, Galizia G, Ciardiello F, Orditura M. De Vita F, et al. Among authors: diana a. BMC Cancer. 2016 Sep 2;16(1):709. doi: 10.1186/s12885-016-2671-9. BMC Cancer. 2016. PMID: 27590845 Free PMC article.

9

Neutrophil to Lymphocyte Ratio as a Predictor of Poor Prognosis in Metastatic Pancreatic Cancer Patients Treated with Nab-Paclitaxel plus Gemcitabine: A Propensity Score Analysis.

Ventriglia J, Petrillo A, Huerta Alváro M, Laterza MM, Savastano B, Gambardella V, Tirino G, Pompella L, Diana A, Iovino F, Troiani T, Martinelli E, Morgillo F, Orditura M, Cervantes A, Ciardiello F, De Vita F. Ventriglia J, et al. Among authors: diana a. Gastroenterol Res Pract. 2018 Jun 10;2018:2373868. doi: 10.1155/2018/2373868. eCollection 2018. Gastroenterol Res Pract. 2018. PMID: 29983708 Free PMC article.

10

Three dimensional primary cultures for selecting human breast cancers that are sensitive to the anti-tumor activity of ipatasertib or taselisib in combination with anti-microtubule cytotoxic drugs.

Orditura M, Della Corte CM, Diana A, Ciaramella V, Franzese E, Famiglietti V, Panarese I, Franco R, Grimaldi A, Lombardi A, Caraglia M, Santoriello A, Procaccini E, Lieto E, Maiello E, De Vita F, Ciardiello F, Morgillo F. Orditura M, et al. Among authors: diana a. Breast. 2018 Oct;41:165-171. doi: 10.1016/j.breast.2018.08.002. Epub 2018 Aug 4. Breast. 2018. PMID: 30103105

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

331 results

Search Page